StockData
Adaptive Biotechnologies Corp logo

Adaptive Biotechnologies Corp (ADPT) income statement

ADPTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30
$28.46−0.03 (-0.11%)

Close on Nov 18, 2026Market cap $4.54BP/E –Yield –

Adaptive Biotechnologies Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
75.6%
Operating margin
-12.2%
Net margin
-20.7%
Return on equity, FY2025
-28.2%

Financial strength

Current ratio
4.79
Debt to equity
0.00
Debt to assets
0.0%
Cash to current liabilities
193.7%

Valuation

P/E ratio
–
Price to sales
14.74
Price to book
31.78
Dividend yield
–

See a number that looks wrong?